Mayne Pharma Group Ltd. (AU:MYX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mayne Pharma Group Ltd has announced the cessation of 34,073 performance rights due to conditions not being met by the stipulated deadline of May 3, 2024. This financial update is crucial for investors tracking the performance and management decisions of the pharmaceutical company.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.